Showing results (2171-2180 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|June 13, 2012
Hospital reimbursement price cap for cancer drugs: the French experience in controlling hospital drug expendituresA Degrassat-Théas, M Bensadon, C Rieu, et al.Pharmacoeconomics|May 23, 2012
Cost effectiveness of rituximab for non-Hodgkin's lymphoma: a systematic reviewPhilipp W P Auweiler, Dirk Müller, Stephanie Stock, et al.Pharmacoeconomics|October 5, 2013
Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar I disorder in children and adolescents: a NICE single technology appraisalLesley Uttley, Ben Kearns, Shijie Ren, et al.Pharmacoeconomics|October 12, 2013
Eliciting preferences for prioritizing treatment of rare diseases: the role of opportunity costs and framing effectsArna S Desser, Jan Abel Olsen, Sverre GrepperudPharmacoeconomics|May 18, 2012
Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation modelsKristian BolinPharmacoeconomics|May 18, 2012
Cost effectiveness of quetiapine in patients with acute bipolar depression and in maintenance treatment after an acute depressive episodeMattias Ekman, Peter Lindgren, Carolin Miltenburger, et al.Pharmacoeconomics|March 4, 2010
Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populationsStephanie R Earnshaw, Cheryl L McDade, Libby K Black, et al.Pharmacoeconomics|March 13, 2010
Does the funding source influence the results in economic evaluations? A case study in bisphosphonates for the treatment of osteoporosisRachael L Fleurence, D Eldon Spackman, Christopher HollenbeakPharmacoeconomics|October 21, 2005
Measuring health-related quality of life in older patient populations: a review of current approachesAnne Hickey, Maja Barker, Hannah McGee, et al.Pharmacoeconomics|October 21, 2005
Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux diseaseDyfrig A Hughes, Keith Bodger, Peter Bytzer, et al.Pageof 336